(Q35987881)

11 August 2017

0 references

1 reference

title

Meta-analysis: Effect of hepatitis C virus infection on mortality in dialysis (English)

1 reference

11 August 2017

0 references

1 reference

1 reference

1 reference

Fabrizi F

1

1 reference

11 August 2017

Martin P

2

1 reference

11 August 2017

Dixit V

3

1 reference

11 August 2017

Bunnapradist S

4

1 reference

11 August 2017

Dulai G

5

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 December 2004

1 reference

Alimentary Pharmacology & Therapeutics

11 August 2017

published in

1 reference

11 August 2017

volume

20

1 reference

11 August 2017

issue

11-12

1 reference

11 August 2017

page(s)

1271-1277

1 reference

Hepatitis C infection and the patient with end-stage renal disease

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02290.X

National surveillance of dialysis-associated diseases in the United States, 2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02290.X

Cancer in patients on dialysis for end-stage renal disease: an international collaborative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02290.X

Hepatitis C virus infection in renal failure patients in the absence of anti-hepatitis C virus antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02290.X

The retrieval of randomized clinical trials in liver disease from the medical literature. A comparison of MEDLARS and manual methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02290.X

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02290.X

Effects of hepatitis C infection and renal transplantation on survival in end-stage renal disease. The New England Organ Bank Hepatitis C Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02290.X

Risk of death and liver cirrhosis in anti-HCV-positive long-term haemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02290.X

Quantitation of hepatitis C viral RNA in sera of hemodialysis patients: gender-related differences in viral load

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02290.X

Chronic hepatitis C infection in patients with end stage renal disease: characterization of liver histology and viral load in patients awaiting renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02290.X

Histopathological features of hepatitis C in renal transplant candidates [see comment]

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02290.X

Liver disease patterns in hemodialysis patients with antibodies to hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02290.X

Liver disease in dialysis patients with antibodies to hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02290.X

Host defenses and immunologic alterations associated with chronic hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02290.X

10.1111/J.1365-2036.2004.02290.X

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference